cbdMD, Inc. Common Stock (YCBD)

Price$0.72

Value ScoreB

Growth ScoreC

Momentum ScoreC

Favorite Metrics

Price vs S&P 500 (26W)9.15%

Price vs S&P 500 (4W)-13.86%

VGM Score55.52

Market Capitalization$7.35M

All Metrics

Book Value / Share (Quarterly)$0.88

P/TBV (Annual)2.11x

Revenue Growth (3Y)-18.46%

Cash Flow / Share (Quarterly)$-0.25

Price vs S&P 500 (YTD)-54.57%

Gross Margin (TTM)59.38%

Net Profit Margin (TTM)-13.29%

EPS (TTM)$-0.34

10-Day Avg Trading Volume0.21M

EPS Excl Extra (TTM)$-0.34

Revenue Growth (5Y)-14.45%

EPS (Annual)$-0.51

Dividend / Share (Annual)$0.00

ROI (Annual)-28.24%

Gross Margin (Annual)62.37%

Net Profit Margin (5Y Avg)-75.03%

Cash / Share (Quarterly)$0.25

Revenue Growth QoQ (YoY)18.75%

ROA (Last FY)-19.59%

Revenue Growth TTM (YoY)2.00%

EBITD / Share (TTM)$-0.19

ROE (5Y Avg)-143.31%

Operating Margin (TTM)-13.40%

Cash Flow / Share (Annual)$-0.18

P/B Ratio0.79x

P/B Ratio (Quarterly)0.84x

Net Income / Employee (Annual)$-48,600

EV / Revenue (TTM)0.24x

Net Interest Coverage (TTM)-7.06x

ROA (TTM)-23.96%

EV / EBITDA (TTM)0.39x

EPS Incl Extra (Annual)$-0.51

Current Ratio (Annual)2.05x

Quick Ratio (Quarterly)1.42x

3-Month Avg Trading Volume1.47M

52-Week Price Return-26.17%

Revenue / Employee (TTM)$475,800

Tangible BV / Share (Quarterly)$0.68

P/S Ratio (Annual)0.38x

Asset Turnover (Annual)1.84x

52-Week High$2.56

Operating Margin (5Y Avg)-74.98%

EPS Excl Extra (Annual)$-0.51

CapEx CAGR (5Y)-32.56%

Tangible BV CAGR (5Y)-20.44%

26-Week Price Return17.07%

Quick Ratio (Annual)1.03x

13-Week Price Return1.86%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)2.82x

Enterprise Value$4.72M

Revenue / Share Growth (5Y)-35.24%

Asset Turnover (TTM)1.80x

Book Value / Share Growth (5Y)-58.51%

Revenue / Employee (Annual)$456,900

Inventory Turnover (Annual)2.83x

Pretax Margin (Annual)-10.63%

Cash / Share (Annual)$0.25

3-Month Return Std Dev83.93%

Gross Margin (5Y Avg)63.30%

Net Income / Employee (TTM)$-63,200

ROE (Last FY)-28.24%

Net Interest Coverage (Annual)-8.49x

EPS Basic Excl Extra (Annual)$-0.51

Receivables Turnover (TTM)15.23x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-0.34

Receivables Turnover (Annual)18.96x

ROI (TTM)-33.59%

P/S Ratio (TTM)0.37x

Pretax Margin (5Y Avg)-75.43%

Revenue / Share (Annual)$4.77

Tangible BV / Share (Annual)$0.57

Price vs S&P 500 (52W)-50.54%

Year-to-Date Return-46.41%

5-Day Price Return-8.19%

EPS Normalized (Annual)$-0.51

ROA (5Y Avg)-77.34%

Net Profit Margin (Annual)-10.63%

Month-to-Date Return-8.65%

Cash Flow / Share (TTM)$-15.00

EBITD / Share (Annual)$-0.26

Operating Margin (Annual)-11.27%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-129.07%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-0.34

P/TBV (Quarterly)1.10x

P/B Ratio (Annual)1.49x

Dividend / Share (TTM)$0.00

Inventory Turnover (TTM)2.71x

Pretax Margin (TTM)-13.29%

Book Value / Share (Annual)$0.81

Price vs S&P 500 (13W)-6.40%

Dividend Yield (TTM)0.00%

Beta2.08x

Revenue / Share (TTM)$1.91

ROE (TTM)-33.59%

52-Week Low$0.47

vGradeB

gGradeC

mGradeC

vgmGradeC

Show chart for

Earnings Surprise History

Q2 26-0.08est. -0.05

Analyst Recommendations

Mar 2026

Apr 2026

May 2026

Jun 2026

4.14

Industry Peers — Cosmetics & Toiletries(19)

Symbol	Value Score	Growth Score	Momentum Score	Price
YCBDcbdMD, Inc. Common Stock	B	C	C	$0.72
CLColgate-Palmolive Company	C	C	C	$88.58
HLNHaleon plc American Depositary Shares (Each representing two Ordinary Shares)	B	B	C	$9.12
KVUEKenvue Inc.	C	C	C	$17.71
ELThe Estee Lauder Companies Inc. Class A	C	D	C	$83.49
ELFe.l.f. Beauty, Inc.	C	B	D	$49.57
IPARInterparfums, Inc. Common Stock	B	B	C	$91.27
COTYCOTY INC	B	C	D	$1.96
OLPXOlaplex Holdings, Inc. Common Stock	C	D	B	$2.04
EPCEdgewell Personal Care Company	B	D	C	$19.87
WALDWaldencast plc Class A Ordinary Share	B	D	C	$1.72

About

cbdMD Inc is a United States-based consumer wellness company that manufactures and distributes CBD and functional mushroom products through three distinct brands: cbdMD, Paw CBD (pet-focused), and ATRx Labs. Its product portfolio includes tinctures, gummies, topicals, capsules, oils, and pet formulations distributed via e-commerce, wholesalers, and retail partnerships. This diversified brand and channel strategy positions the company across multiple consumer wellness segments.